Patent Issuance $18.123M Market Capitalization Filament Health Corp. (FH.NE) announced today that it has been issued a patent by the United States Patent and Trademark Office (USPTO) for the…
psychedelics
Meeting with the FDA $18.123M Market Capitalization Filament Health Corp. (FH.NE) announced today that it has held a pre-investigational new drug application (PIND) meeting with the FDA Division…
Natural Talent Albert Hofmann was a fun guy, pun intended. More importantly, the Swiss chemist is known for being the first person to synthesize, consume, and learn of the psychedelic…
Psychedelics are once again hinting at a major reversal. With Cannabis stocks essentially confirming reversal breakouts, will psychedelics be able to join? It comes down to that catalyst. Will…
Two for Two $23.066M Market Capitalization Filament Health Corp. (FH.NE) announced today that it has been issued a second patent by the Canadian Intellectual Property Office (CIPO) for the…
Modern Day Space Race $23.139M Market Capitalization Optimi Health Corp. (OPTI.C) announced today that it has commenced the cultivation of natural GMP-grade psilocybin mushrooms at its Princeton, British Columbia…
Numinus Wellness (NUMI.T) research lab, Numinus Bioscience, received the nod from the Public Health Agency of Canada for their containment level 2 (CL2) pathogens and toxins license after the…
Numinus Wellness (NUMI.T) got the Health Canada nod to study ayahuasca and San Pedro at its research facility, Numinus Bioscience today. The license expansion works to boost NUMI’s profile…
Standardizing Psychedelic-Assisted Therapy $25.537M Market Capitalization Filament Health Corp. (FH.NE) announced today that it has entered into a licensing agreement with ATMA Journey Centers. Under the agreement, Filament has…
Psyched Wellness (PSYC.C) released the results and data from the three month oral toxicity preclinical trial on its amanita muscaria mushroom (AME-1) extract today, and enjoyed a substantial 19%…